The Global Newborn Screening LC-MS Reagent Kit Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth. In the newborn screening, LC-MS/MS method is mainly applied to the detection of amino acids and acyl carnitines in blood.
Tandem mass spectrometry makes it possible to detect extremely low concentrations of compounds that can be used to indicate whether a baby is likely to have an inborn metabolic disorder.
Scope of the Report:
The classification according to the material of Newborn Screening LC-MS Reagent Kit includes Non-derivatized Assay Solutions, Derivatized Assay Solutions, and the proportion of Non-derivatized Assay Solutions in 2017 is about 65.5%.
Newborn Screening LC-MS Reagent Kit is widely used to test Protein Metabolism, Fatty Acid Metabolism, Organic Acid Metabolism, the most proportion of Newborn Screening LC-MS Reagent Kit is used to test Protein Metabolism, and the proportion in 2017 is about 44.2%.
China is the largest sales place, with a sales market share nearly 21.8% in 2017. The demand for Newborn Screening LC-MS Reagent Kit in China is expected to witness growth owing to the increasing of newborn population.
The worldwide market for Newborn Screening LC-MS Reagent Kit is expected to grow at a CAGR of roughly 4.3% over the next five years, will reach 270 million US$ in 2024, from 210 million US$ in 2019.
This report focuses on the Newborn Screening LC-MS Reagent Kit in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Perkinelmer
- Danaher
- Chromsystems
- Zivak Technologies
- Trivitron (Labsystems)
- BGI
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Non-derivatized Assay Solutions
- Derivatized Assay Solutions
Market Segment by Applications, can be divided into
- Protein Metabolism
- Fatty Acid Metabolism
- Organic Acid Metabolism
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Newborn Screening LC-MS Reagent Kit product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Newborn Screening LC-MS Reagent Kit, with price, sales, revenue and global market share of Newborn Screening LC-MS Reagent Kit in 2017 and 2018.
Chapter 3, the Newborn Screening LC-MS Reagent Kit competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Newborn Screening LC-MS Reagent Kit breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Newborn Screening LC-MS Reagent Kit market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Newborn Screening LC-MS Reagent Kit sales channel, distributors, customers, research findings and conclusion, appendix and data source.